Hypothalamic amenorrhea: From diagnosis to therapeutical approach;Aménorrhée hypothalamique du diagnostic à l'approche thérapeutique

Annales d'Endocrinologie

Volumn 71, Issue 3, 2010, Pages 163-169

  Genazzani, A D ^a   Chierchia, E ^a   Santagni, S ^a   Rattighieri, E ^a   Farinetti, A ^a   Lanzoni, C ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

endorphin; GnRH; Hypoestrogenism; Hypogonadotropic amenorrhea; Hypothalamic amenorrhea; Stress; Weight loss

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LEVACECARNINE; NALTREXONE; PIVAGABINE;

ADAPTATION; ANAMNESIS; ARTICLE; CLINICAL PRACTICE; DIET; DISEASE ASSOCIATION; DISEASE DURATION; EATING DISORDER; EMOTIONAL STRESS; ENDOCRINE DISEASE; FAMILY; HOMEOSTASIS; HUMAN; HYPOTHALAMIC AMENORRHEA; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MENARCHE; MENSTRUAL CYCLE; MENTAL STRESS; METABOLIC STRESS; NEUROENDOCRINE SYSTEM; NONHUMAN; PHYSICAL STRESS; SECONDARY AMENORRHEA; SYSTEMIC DISEASE; TRAINING; WEIGHT REDUCTION; WORK;

AMENORRHEA; EATING DISORDERS; FEMALE; HUMANS; HYPOGONADISM; HYPOTHALAMIC DISEASES; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; PROLACTIN;

EID: 77952742447     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2010.02.006     Document Type: Article

References (55)

1. Batrinos M.L., Panitsa-Faflia C., Courcoutsakis N., Chatzipavlou Incidence, type, and etiology of menstrual disorders in the age group 12-19 years. Adolesc Pediatr Gynecol 1990, 3:149-153.
2. Genazzani A.D. Neuroendocrine aspects of amenorhea related to stress. Pediatr Endocrinol Rev 2005, 2:661-668.
3. Frisch R.E., McArthur J.W. Menstrual cycles: fatness as a determinant of minumun weight for height necessary for their maintenance or onset. Science 1974, 185:949-951.
4. Veldhuis J.D., Evans W.S., Demers L.M. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab 1985, 61:557-562.
5. Cameron J.L., Helmreich D.L., Schreihofer D.A. Modulation of reproductive hormone secretion by nutritional intake: stress signals versus metabolic signals. Hum Reprod 1993, 8:162-167.
6. Facchinetti F., Fava M., Fioroni L., et al. Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. Psychoneuroendocrinology 1993, 18:397-404.
7. Cannavo S., Trimarchi F. Exercise-related female reproductive dysfunction. J Endocrinol Invest 2001, 24:823-832.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association. Washington, DC., 1995.
9. Genazzani A.D., Petraglia F., Fabbri G., et al. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. Fertil Steril 1990, 54:222-226.
10. Vigersky R.A., Andersen A.E., Thompson R.H., Lauriaux D.L. Hypothalamic dysfunctuion in secondary amenorrhea associated with weight loss. N Engl J Med 1977, 297:1141-1146.
11. Berga S.L., Mortola S.F., Girton L., et al. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1989, 68:301-308.
12. Genazzani A.D., Petraglia F., Gastaldi M., et al. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile and postmenopausal women. Am J Physiol 1993, 264:E776-E781.
13. Genazzani A.D., Petraglia F., Benatti R., et al. Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. J Clin Endocrinol Metab 1991, 72:1220-1225.
14. Genazzani A.D., Petraglia F., Gastaldi M., et al. Episodic release of prolactin in women with weight loss releated amenorrhea. Gynecol Endocrinol 1994, 8:95-100.
15. Fioroni L., Fava M., Genazzani A.D., et al. Life events impact in patients with secondary amenorrhea. J Psychosom Res 1994, 6:617-622.
16. Quigley M.E., Sheehan K.L., Casper R.F., Yen S.S. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1980, 50:949-954.
17. Petraglia F., Panerai A.E., Rivier C., et al. Opioid control of gonadotropin secretion. Brain and female reproductive function 1988, 65-72. Parthenon, Carnforth, UK. A.R. Genazzani, U. Montemagno, C. Nappi, F. Petraglia (Eds.).
18. Rivier C., Rivier C.V., Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 1986, 231:607-609.
19. Petraglia F., Sutton S., Vale W., Plotsky O. Corticotropin-releasing factor decrease plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophyseal portal circulation. Endocrinology 1987, 120:1083-1088.
20. Petraglia F., Vale W., Rivier C. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. Endocrinology 1986, 119:2445-2450.
21. Nappi R.E., Petraglia F., Genazzani A.D., et al. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. Fertil Steril 1993, 59:571-576.
22. Robel P., Baulieu E.E. Neurosteroids: biosynthesis and function. Crit Rev Neurobiol 1995, 9:383-394.
23. Genazzani A.D., Petraglia F., Volpe A., Genazzani A.R. Hypothalamic amenorrhea: neuroendocrine mechanisms/stress-induced anomalies. Assist Reprod Technol/Androl 1997, 9:1-13.
24. Genazzani A.D., Luisi M., Malavasi B., Strucchi C., Luisi S., Casarosa E., Bernardi F., Genazzani A.R., Petraglia F. Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol 2002, 146:347-356.
25. Meczekalski B., Tonetti A., Monteleone P., et al. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropinreleasing hormone test. Eur J Endocrinol 2000, 142:280-285.
26. Genazzani A.R., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., et al. Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J Clin Endocrinol Metab 1998, 83:1-5.
27. Meczekalski B., Podfigurna-Stopa, Warenik-Szymankiewicz A., Genazzani A.R. Functional hypothalamic amenorrhea: Current view on neuroendocrine aberrations. Gynecol Endocrinol 2008, 24:4-11.
28. Meczekalski B., Tonetti A., Monteleone P., Bernardi F., Luisi S., Stomati M., et al. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. Eur J Endocrinol 2000, 142:280-285.
29. Genazzani A.D., Strucchi C., Malavasi B., Tortolani F., Vecchi F., Luisi S., et al. Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea. Gynecol Endocrinol 2001, 15:279-285.
30. Kamel F., Kubajak C.L. Modulation of gonadotropic secretion by corticosterone interaction with gonadal steroids and mechanism of action. Endocrinology 1987, 121:561-568.
31. Gala R.R. The physiology and mechanisms of stress-induced changes in prolactin secretion in rat. Life Sci 1990, 46:1407-1410.
32. Onofrj M., Bodis-Wollner I., Pola P., Calvani M. Central cholinergic effects of levo-acetyl-carnitine. Drugs Exp Clin Res 1983, 9:161-167.
33. Janiri L., Tempesta E. A pharmacological profile of the effects of carnitine and acetyl-L-carnitine on the central nervous system. Int J Clin Pharmacol Res 1983, 3:295-306.
34. Tempesta E., Janiri L., Pirroncelli C. Stereospecific effects of acetyl-Lcarnitine on the spontaneous activity of brain stem neuronesa and their responses to acethylcoline and serotonin. Neuropharmacology 1985, 24:43-50.
35. Testa G., Angelini C. Apreliminary trial with acetyl-L-carnitine (A-Cn) in dementia. Curr Rep Neurol 1981, 5:4-16.
36. Krsmanovic L.Z., Virmani M.A., Stojikovic S.S., Catt K.J. Actions of acetyl-L-carnitine on gonadotrophin secretion. Gynecol Endocrinol 1992, 6(Suppl 1):11.
37. Quigley M.E., Yen S.S.C. The role of endogenous opiates on LH secretion during the menstrual cycle. J Clin Endocrinol Metab 1980, 51:179-181.
38. Petraglia F., D'Aambrogio G., Comitini G., et al. Impairment of opiod control of luteinizing hormone secretion in menstrual disorders. Fertil Steril 1985, 43:535-540.
39. Petraglia F., Porro C., Facchinetti F., et al. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sci 1986, 38:2103-2110.
40. Wildt L., Leyendecker G., Sir-Petermann T., Waiberl-Treber S. Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Hum Reprod 1993, 8:350-358.
41. Biggio G., Sanna E., Serra M., Costa E. GABAa receptors and anxiety. Advances in Biochemistry and Psychopharmacology 1995, 48. Raven Press, New York, NY.
42. Biggio G., Concas A., Corda M.G., et al. GABAergic and dopaminergic trasmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther 1990, 48:121-142.
43. Concas A., Serra A.M., Atsoggiu T., Biggio G. Foot shock and anxuiogenic beta-carbolines increase t-[35S]-butylbicyclophosphorotionate binding in the rat cerebral cortex, an effect opposite to anxiolytic and gamma-aminobutyric acid mimetics. J Neurochem 1988, 51:1868-1876.
44. Kalogeras K.T., Calogero A.E., Kuribayiashi T., et al. In vitro and in vivo effects of triazolobenzodiazepine alprazolam and hypothalamic-pituitaryadrenal function: pharmacological and clinical implications. J Clin Endocrinol Metab 1990, 70:1462-1471.
45. Imaki T., Vale W. Chordiazepoxide attenuates stress-induced accumulation of corticotropin releasing factor mRNA in paraventricularnucleous. Brain Res 1993, 623:223-228.
46. Imaki T., Xiao-Quan W., Shibasaki Y., et al. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF), gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol Brain Res 1995, 32:261-270.
47. Galzigna L., Garbin L., Bianchi M., Marzotto A. Properties of two derivatives of gamma-aminobutyric acid (GABA) capable of abolishing Cardiazol- and bicuculline-induced convulsions in the rat. Arch Int Pharmacodyn Ther 1978, 235:73-85.
48. Esposito G., Luparini M.R. Pivagabine: a novel psychoactive drug. Arzneim Forsch Drug Res 1997, 47:1306-1309.
49. Scapagnini U., Matera M. Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress. Arznein Forsch Drug Res 1997, 47:1310-1317.
50. Serra M., Concas A., Mostallino M.C., et al. Antagonism by pivagabine of stress-induced changes in GABAa receptor function and corticotropinreleasing factor concentrations in rat brain. Psychoneuroendocrinology 1999, 24:269-284.
51. Genazzami A.D., Stomati M., Bersi C., et al. Pivagabine decreases stressrelated hormone secretion in women with hypothalamic amenorrhea. J Endocrinol Invest 2000, 23:526-532.
52. Ferin M. Stress and the reproductive cycle. J Clin Endocrinol Metab 1999, 84:1768-1774.
53. Cameron J.L. Regulation of reproductive hormone secretion in primates by short-term changes in nutrition. Rev Reprod 1996, 1:117-126.
54. Giglioli B., Multinu A., Lai V.R. Role of pivagabine in the treatment of climateric syndrome. Arzneim Forsch Drug Res 1997, 47:1317-1321.
55. Barbarino A., Corsello S.M., Della Casa S., et al. Corticotropin releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J Clin Endocrinol Metab 1990, 71:1368-1374.